Call for papers Revised by January 12, 2012
CLINAM 5/2012 with ETPN
The European Summit for Clinical Nanomedicine
Basel, Switzerland, Monday, May 7, 09.00 am – Wednesday, May 9, 2011, 5.00 pm
Deadline for submission of papers and of posters
The deadline for submission is March 23, 2012. Submitted papers will undergo peer grading. Accepted papers are chosen for oral short lecture or poster presentation. If you decide to go for a poster only, the absolute deadline is April 5, 2012.
Scientific and clinical fields
Papers submitted must cover original research aimed at future or current clinical application of nanoscience. This includes clinical trial designs, reports of ongoing and completed clinical trials, preclinical work, and technology papers with a clinical long-term vision. Submitted papers will undergo peer grading. Accepted papers are chosen for oral or poster presentation. The session topics will include: • Rheumatic disease • Cardiovascular disease • Cancer • Gastrointestinal/hepatic disease • Bacterial infection • Viral infection • Parasitic infection • Implant infection • Multiresistant bacteria • Tuberculosis • HIV, etc.
Avalable sessions
1. Sessions on clinical topics
Nanomedicine for cardiovascular disease, rheumatic disease, oncology, gastrointestinal/hepatic disease, bacterial infection, viral infection, parasitic Infection, implant infection, tuberculosis, haematology, neurology / neurosurgery, implants, inflammation, orphan diseases, dermatology, eye disease, ear disease, tissue repair, orthopaedics and many others.
2. Sessions on technology
Nano-systems, nanoparticles, nano-analytics and diagnostics, toxicology, nano-imaging, targeted drug delivery using nanoparticles, GMP and quality assurance, and others, propositions for solving a medical problem in a novel way by the use of nanotechnology, novel concepts and ideas if they can be supported by thorough reasoning and could lead to novel research and solutions.
3. Sessions on the implications
Implications of nanomedicine for society, developing countries, the environment, risks and benefits, public health finance, health economics, and other subjects.
4. Sessions on strategy building and policy processes in Nanomedicine
Strategic approaches towards establishing a unified funding area for nanotechnologies for medical research. Policy processes to foster European leadership in Nanomedicine
Submission format and Procedure: (Deadline for submission is March 23, 2012)
The submission must be written in Microsoft Word, RTF, or Open document file format, using Times New Roman 12 point font size with single spacing and must not be longer than three pages, including metadata and figures (one figure is obligatory). All illustrations, figures, and tables are placed within the text at the appropriate points.
Please send us your paper, a short CV and your portrait photo in gif or jpg to the address This e-mail address is being protected from spambots. You need JavaScript enabled to view it
Check if you have included the following material before submitting
- Your paper / poster
- Your short CV ( ½ - max. 1 page)
- A portrait photo in best resolution as jpg or tiff high resolution
- If you need an official invitation letter, state this and add it in a separate small letter.
- An eventual Application for Fellowship should be added as a separate letter
Presentation Times and Size of Posters
Posters will be located in the Foyer visible for all conference attendees. Due to the tight conference schedule the meeting breaks and lunches will be the preferred time to study the posters. Therefore, during lunch and breaks the authors are asked to be present close to their poster. In addition to that after the sessionsthere is on both first days of the conference 1 hour dedicated to viewing the posters. Posters are to be presented in the size of 1.40 meter wide and 1.00 meter high. In 2012 there will be the CLINAM-Poster Prize as well as the special poster award for Nanotoxicology by the European Center for Nanotoxicology (ENT), Graz, Austria. It will be handed out on the third Day of the conference during lunch time.
Notification on acceptance or rejection and billing:
The decisions of acceptance or declination of your submitted work will be taken before April 5, 2012. You will receive a “Decision Form” which – in case of acceptance - has to be returned within 4 Days after receipt After that you have to register within one week online and will receive a bill which is to be paid not later than by April 10, 2012.
Installation of Posters:
Poster installation on May 7 as from 06.45 until 8.30. You will receive at the reception the location number of your wall.
Questions
For further questions please contact our team at
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
“Small Talk” Sessions
Posters and results are eligible for presentations in a special session of Small Talks, 4 minutes in length and serving to highlight the research activities in Nanotechnology in Health. The Small Talk must comprise a maximum of three slides, • Slide 1: general introduction to the topic of your field, presented in a way that is accessible to the highly interdisciplinary audience • Slide 2: some of the highlights of submitters work and institutions work • Slide 3: the prove how the work at the University/Institute fits into the area of Nanomedicine including showing the future. Application for Small Talk Sessions are possible any time after acceptance of your Poster
Responsible Organiser
The European CLINAM Foundation for Clinical Nanomedicine, Basel, Switzerland
(www.clinam.org) together with the European Society for Nanomedicine and the European Technology Platform on Nanomedicine (ETPN) (www.etp-nanomedicine.eu)
Responsibility
Beat Löffler, MA, CEO of the European Foundation for Clinical Nanomedicine and
Prof. Dr. med. Patrick Hunziker, MD, CSO of the European Foundation for Clinical Nanomedicine
Dr. Sebastian Lange, Managing Director of the European Technology Platform on Nanomedicine, Berlin (D)
Office
European Foundation for Clinical Nanomedicine (CLINAM-FOUNDATION)
Alemannengasse 12, P.O. Box, CH-4016 Basel, Switzerland
Phone: + 41 61 695 93 95
Fax: + 41 61 695 93 90
Mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it